-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast Cancer
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer Diagnosis
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
-
Disparities in Breast Cancer Outcomes for Black Women Despite Similar Recurrence Scores
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
by Eric Fitzsimmons
Cancer Talk
An Evidence-Based Guide to Integrative Medicine
ASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.
by Teresa Bergen
Comparing Costs of At-Home Colorectal Screening TestsCologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
A Personal Journey of Thyroid Cancer TreatmentThe practical side of cancer treatment and life without a thyroid.
by Carly Flumer
Women Less Satisfied With Cancer CareCompared with men, women’s initial cancer symptoms are less likely to be taken seriously.
by Sandra Gordon